Biomarkers of Metabolic Syndrome in Clinical Trials
This will discuss the latest developments in biomarkers for metabolic syndrome. The topics will include: 1) Pre-analytical and analytical concerns regarding gut and incretin hormones, 2) dysfunctional HDL biomarkers in metabolic syndrome, and 3) kidney injury markers and their usefulness in diabetic nephropathy.
iASPP, a Potential Drug Target in Cancer Therapy
Sebastien Gillotin, Professor, Oxford University, speaking at Screening Europe 2010
Direct Cellular Patterning and Analysis Using a Novel Microprinting Technology
Nathaniel C. Cady, Assistant Professor of Nanobioscience, College of Nanoscale Science & Engineering, speaking at Single Analysis Summit 2010.
Procalcitonin (PCT) Webinar - How to Incorporate Procalcitonin (PCT) into your Facility's Sepsis Initiative
In this webinar Kirsten R. Pyle-Springer, Sepsis Coordinator at Surgical/Neuro/Trauma Intensive Care Unit, Mission Hospital in Mission Viejo, California discusses the Awareness of Sepsis and the risk of Sepsis in critical care settings.
From Target Focused to High Content Screening in Nutraceutical Discovery
Ann Fowler, Senior Scientist, DSM Nutritional Products, speaking at Screening Europe
Primary, iPS and Stem Cells: Emerging Tools for HTS?
Richard Elgen, President, Bio-discovery, PerkinElmer, speaking at Screening Europe 2010
High-throughput Screening in Human Embryonic Stem Cells for Drug Discovery
Sabrina C. Desbordes, Senior Postdoctoral Fellow, PRBB-Center for Genomic Regulation (CRG), speaking at Screening Europe 2010
Development of an AlphaScreen Assay for Epigenetic Peptide-Protein Interactions: A Target-Family Approach to the Discovery of MBT Antagonists
Tim Wigle, Researcher, University of North Carolina, speaking at Probe Discovery 2009
T-Cell Monitoring of Clinical Samples – Precise and Robust Assays based on DNA Methylation Markers
Ulrich Hoffmueller, Chief Business Officer, Epiontis GmbH, speaking at European Biomarkers Summit 2009